DR. MICHELE A GORTAKOWSKI M.D.
Prescription History 1710243621
Internal Medicine - Endocrinology, Diabetes & Metabolism in Springfield, MA
Medicare Part D Prescription History
Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. MICHELE A GORTAKOWSKI M.D., an active Endocrinology, Diabetes & Metabolism specialist practicing in Springfield, MA. Our medical registry currently tracks 27 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 762 documented patient claims. Among these therapy options, the most frequently utilized medication is Levothyroxine Sodium, which accounts for 123 claims alone. Use the table below to sort by claims, cost, or utilization compared with the state average; select any medication for its full profile.
| Medication | Prescriptions (2024)Rx (2024) | Avg Cost per FillCost / Fill | Vs. Other MA PrescribersVs. MA Avg |
|---|---|---|---|
| Levothyroxine Sodium | 123 | $12.91 | ≈ Typical |
About Levothyroxine Sodium: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 123 Medicare prescriptions for Levothyroxine Sodium, about the same volume as the typical Massachusetts prescriber of this medication (122.8). Medicare paid an average of $12.91 per fill, versus $10.45 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 243.7 30-Day Fills standardized to 30-day supplies 7,312 Days of Medication total across all patients in 2024 | |||
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 60 | $126.05 | ▲ More than typical |
About Lantus Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. A recombinant LONG ACTING INSULIN and HYPOGLYCEMIC AGENT that is used to manage BLOOD GLUCOSE in patients with DIABETES MELLITUS. In 2024, this provider wrote 60 Medicare prescriptions for Lantus Solostar, about 1.5 times the volume of the typical Massachusetts prescriber of this medication (40). Medicare paid an average of $126.05 per fill, versus $121.42 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 86 30-Day Fills standardized to 30-day supplies 2,465 Days of Medication total across all patients in 2024 | |||
| Alendronate Sodium | 51 | $9.31▼ below MA avg | ≈ Typical |
About Alendronate Sodium: Alendronate is used to prevent and treat certain types of bone loss (osteoporosis) in adults. Show more ▾ Osteoporosis causes bones to become thinner and break more easily. Your chance of developing osteoporosis increases as you age, after menopause, or if you are taking corticosteroid medications (such as prednisone) for a long time. This medication works by slowing bone loss. This effect helps maintain strong bones and reduce the risk of broken bones (fractures). Alendronate belongs to a class of drugs called bisphosphonates. A nonhormonal medication for the treatment of postmenopausal osteoporosis in women. This drug builds healthy bone, restoring some of the bone loss as a result of osteoporosis. In 2024, this provider wrote 51 Medicare prescriptions for Alendronate Sodium, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (42.5). Medicare paid an average of $9.31 per fill, versus $10.03 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 117.4 30-Day Fills standardized to 30-day supplies 3,489 Days of Medication total across all patients in 2024 | |||
| Methimazole | 49 | $8.62▼ below MA avg | ▲ More than typical |
About Methimazole: Methimazole is used to treat overactive thyroid (hyperthyroidism). Show more ▾ It works by stopping the thyroid gland from making too much thyroid hormone. A thioureylene antithyroid agent that inhibits the formation of thyroid hormones by interfering with the incorporation of iodine into tyrosyl residues of thyroglobulin. This is done by interfering with the oxidation of iodide ion and iodotyrosyl groups through inhibition of the peroxidase enzyme. In 2024, this provider wrote 49 Medicare prescriptions for Methimazole, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (39). Medicare paid an average of $8.62 per fill, versus $11.78 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 68.8 30-Day Fills standardized to 30-day supplies 1,984 Days of Medication total across all patients in 2024 | |||
| TrulicityDulaglutide | 39 | $982.95▼ below MA avg | ≈ Typical |
About Trulicity: Dulaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. This medication is also used to lessen the risk of a major cardiovascular event (such as heart attack or stroke) in people who already have, or are at high risk for heart/blood vessel disease. Dulaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and by decreasing the amount of sugar your liver makes. Dulaglutide is not a substitute for insulin if you need insulin treatment. A glucagon-like peptide-1 receptor agonist; GLP-1 immunoglobulin G (IgG4) Fc fusion protein with extended activity. In 2024, this provider wrote 39 Medicare prescriptions for Trulicity, about 79% of the volume of the typical Massachusetts prescriber of this medication (49.1). Medicare paid an average of $982.95 per fill, versus $1,207.77 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 39 30-Day Fills standardized to 30-day supplies 1,106 Days of Medication total across all patients in 2024 | |||
| Testosterone | 38 | $124.37▼ below MA avg | ▲ More than typical |
About Testosterone: This medicated gel contains testosterone. Show more ▾ It is used for hormone replacement in men who are not able to produce enough testosterone (for example, due to hypogonadism). This medication is absorbed through the skin, enters your bloodstream, and helps your body reach normal testosterone levels. Testosterone helps the body to develop and maintain the male sexual characteristics (masculinity), such as a deep voice and body hair. It also helps to maintain muscle and prevent bone loss, and is necessary for natural sexual ability/desire. This drug should not be used by women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2024, this provider wrote 38 Medicare prescriptions for Testosterone, about 1.3 times the volume of the typical Massachusetts prescriber of this medication (30.3). Medicare paid an average of $124.37 per fill, versus $140.94 statewide. How often this provider prescribes it This provider prescribes this medication more often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 38 30-Day Fills standardized to 30-day supplies 1,070 Days of Medication total across all patients in 2024 | |||
| Hydrocortisone | 32 | $31.99 | ≈ Typical |
About Hydrocortisone: This medication is used to treat a variety of skin conditions (such as insect bites, poison oak/ivy, eczema, dermatitis, allergies, rash, itching of the outer female genitals, anal itching). Show more ▾ Hydrocortisone reduces the swelling, itching, and redness that can occur in these types of conditions. This medication is a mild corticosteroid. The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. In 2024, this provider wrote 32 Medicare prescriptions for Hydrocortisone, about 1.2 times the volume of the typical Massachusetts prescriber of this medication (27). Medicare paid an average of $31.99 per fill, versus $15.44 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 44.8 30-Day Fills standardized to 30-day supplies 1,244 Days of Medication total across all patients in 2024 | |||
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 29 | $498.92 | ≈ Typical |
About Basaglar Kwikpen U-100: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. This monograph is about the following insulin glargine products: insulin glargine, insulin glargine-aglr, and insulin glargine-yfgn. In 2024, this provider wrote 29 Medicare prescriptions for Basaglar Kwikpen U-100, about the same volume as the typical Massachusetts prescriber of this medication (31). Medicare paid an average of $498.92 per fill, versus $412.05 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 57.5 30-Day Fills standardized to 30-day supplies 1,714 Days of Medication total across all patients in 2024 | |||
| OzempicSemaglutide | 29 | $899.21▼ below MA avg | ▼ Less than typical |
About Ozempic: Semaglutide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Semaglutide is also used in people with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Semaglutide is similar to a natural hormone in your body (incretin). It works by causing insulin release in response to high blood sugar (such as after a meal) and decreasing the amount of sugar your liver makes. If you use insulin, semaglutide is not a substitute for insulin treatment. A glucagon-like peptide and GLP-1 agonist used to enhance glycemic control of TYPE 2 DIABETES MELLITUS, and for OBESITY MANAGEMENT. In 2024, this provider wrote 29 Medicare prescriptions for Ozempic, about half the volume of the typical Massachusetts prescriber of this medication (50.9). Medicare paid an average of $899.21 per fill, versus $1,217.01 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 31.6 30-Day Fills standardized to 30-day supplies 896 Days of Medication total across all patients in 2024 | |||
| Humalog Kwikpen U-100Insulin Lispro | 26 | $238.14▼ below MA avg | ≈ Typical |
About Humalog Kwikpen U-100: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 26 Medicare prescriptions for Humalog Kwikpen U-100, about 76% of the volume of the typical Massachusetts prescriber of this medication (34.2). Medicare paid an average of $238.14 per fill, versus $252.24 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 33.5 30-Day Fills standardized to 30-day supplies 922 Days of Medication total across all patients in 2024 | |||
| Testosterone Cypionate | 25 | $40.12 | ▼ Less than typical |
About Testosterone Cypionate: This medication is used in men who do not make enough of a natural substance called testosterone. Show more ▾ In males, testosterone is responsible for many normal functions, including growth and development of the genitals, muscles, and bones. It also helps cause normal sexual development (puberty) in boys. Testosterone belongs to a class of drugs known as androgens. It works by affecting many body systems so that the body can develop and function normally. Testosterone may also be used in certain adolescent boys to cause puberty in those with delayed puberty. Some brands may also be used to treat certain types of breast cancer in women. A potent androgenic steroid and major product secreted by the LEYDIG CELLS of the TESTIS. Its production is stimulated by LUTEINIZING HORMONE from the PITUITARY GLAND. In turn, testosterone exerts feedback control of the pituitary LH and FSH secretion. Depending on the tissues, testosterone can be further converted to DIHYDROTESTOSTERONE or ESTRADIOL. In 2024, this provider wrote 25 Medicare prescriptions for Testosterone Cypionate, about 69% of the volume of the typical Massachusetts prescriber of this medication (36.5). Medicare paid an average of $40.12 per fill, versus $23.80 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 26.7 30-Day Fills standardized to 30-day supplies 748 Days of Medication total across all patients in 2024 | |||
| Novolog FlexpenInsulin Aspart | 24 | $191.79▼ below MA avg | ▼ Less than typical |
About Novolog Flexpen: Insulin aspart is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin aspart is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin aspart starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin that has been modified to contain an ASPARTIC ACID instead of a PROLINE at position 38 of the B-chain. In 2024, this provider wrote 24 Medicare prescriptions for Novolog Flexpen, about 72% of the volume of the typical Massachusetts prescriber of this medication (33.4). Medicare paid an average of $191.79 per fill, versus $217.45 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 26 30-Day Fills standardized to 30-day supplies 623 Days of Medication total across all patients in 2024 | |||
| JardianceEmpagliflozin | 23 | $627.70▼ below MA avg | ▼ Less than typical |
About Jardiance: Empagliflozin is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Empagliflozin is also used in patients with type 2 diabetes and heart disease to lower the risk of death from heart attack or stroke. Empagliflozin works by increasing the removal of sugar by your kidneys. Empagliflozin is also used to treat heart failure and kidney disease. It helps to lower the risk of death from heart disease and reduces the need of going to a hospital to treat heart failure or kidney disease. It also helps to lower the risk of dialysis in people with kidney disease. Empagliflozin works by increasing the removal of sodium by your kidneys. In 2024, this provider wrote 23 Medicare prescriptions for Jardiance, about half the volume of the typical Massachusetts prescriber of this medication (49.3). Medicare paid an average of $627.70 per fill, versus $1,010.43 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 25 30-Day Fills standardized to 30-day supplies 750 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 22 | $100.40 | ≈ Typical |
In 2024, this provider wrote 22 Medicare prescriptions for Ultra-Fine Mini Pen Needle, about 84% of the volume of the typical Massachusetts prescriber of this medication (26.3). Medicare paid an average of $100.40 per fill, versus $91.93 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 34.4 30-Day Fills standardized to 30-day supplies 1,009 Days of Medication total across all patients in 2024 | |||
| Estradiol (Twice Weekly)Estradiol | 20 | $83.00▼ below MA avg | ≈ Typical |
About Estradiol (Twice Weekly): This medication is a hormone (estrogen). Show more ▾ It is used by women to help reduce symptoms of menopause (such as hot flashes, vaginal dryness). These symptoms are caused by the body making less estrogen. If you are using this medication to treat symptoms only in and around the vagina, products applied directly inside the vagina should be considered before medications that are taken by mouth, absorbed through the skin, or injected. This medication may also be used by women who are not able to produce enough estrogen (for example, due to hypogonadism, primary ovarian failure). Certain estrogen products may also be used by women after menopause to prevent bone loss (osteoporosis). However, there are other medications (such as raloxifene, bisphosphonates including alendronate) that are also effective in preventing bone loss and may be safer. These medications should be considered for use before estrogen treatment. The 17-beta-isomer of estradiol, an aromatized C18 steroid with hydroxyl group at 3-beta- and 17-beta-position. Estradiol-17-beta is the most potent form of mammalian estrogenic steroids. In 2024, this provider wrote 20 Medicare prescriptions for Estradiol (Twice Weekly), about 90% of the volume of the typical Massachusetts prescriber of this medication (22.3). Medicare paid an average of $83.00 per fill, versus $98.01 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 27.6 30-Day Fills standardized to 30-day supplies 688 Days of Medication total across all patients in 2024 | |||
| SynarelNafarelin Acetate | 19 | $3,398.60 | – No State Data |
About Synarel: Nafarelin is used in women to treat a condition in which the tissue that normally lines the inside of the uterus grows in the wrong place (endometriosis). Show more ▾ This medication helps to decrease the abnormal tissue and also the symptoms of endometriosis (such as pelvic pain, painful menstrual cramps, and pain during/after sex). This medication is also used by children to treat a certain type of early puberty (central precocious puberty, gonadotropin-dependent). It helps to slow the bone aging and height growth rate so that both are near normal, and it helps to stop or reverse signs of early puberty (such as breast growth in girls, growth of sexual organs in boys). Nafarelin is similar to a natural hormone made by the body (gonadotropin-releasing hormone-GnRH). It works by decreasing the testosterone hormones in boys and estrogen hormones in women and girls. A potent synthetic agonist of GONADOTROPIN-RELEASING HORMONE with 3-(2-naphthyl)-D-alanine substitution at residue 6. Nafarelin has been used in the treatments of central PRECOCIOUS PUBERTY and ENDOMETRIOSIS. In 2024, this provider wrote 19 Medicare prescriptions for Synarel. Medicare paid an average of $3,398.60 per fill. No state comparison is available for this medication. How often this provider prescribes it No state benchmark is available for this medication. What Medicare paid per fill $3,398.60 Cost per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 19 30-Day Fills standardized to 30-day supplies 480 Days of Medication total across all patients in 2024 | |||
| Ultra-Fine Nano Pen NeedlePen Needle, Diabetic | 16 | $121.05 | ≈ Typical |
In 2024, this provider wrote 16 Medicare prescriptions for Ultra-Fine Nano Pen Needle, about 78% of the volume of the typical Massachusetts prescriber of this medication (20.6). Medicare paid an average of $121.05 per fill, versus $84.25 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 23.3 30-Day Fills standardized to 30-day supplies 700 Days of Medication total across all patients in 2024 | |||
| Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt | 16 | $697.88▼ below MA avg | ≈ Typical |
In 2024, this provider wrote 16 Medicare prescriptions for Omnipod Dash Pods (Gen 4), about 89% of the volume of the typical Massachusetts prescriber of this medication (18). Medicare paid an average of $697.88 per fill, versus $1,067.47 statewide. How often this provider prescribes it This provider's prescribing volume for this medication is in line with the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 20 30-Day Fills standardized to 30-day supplies 600 Days of Medication total across all patients in 2024 | |||
| Spironolactone | 15 | $16.21 | ▼ Less than typical |
About Spironolactone: Spironolactone is used to treat high blood pressure and heart failure. Show more ▾ Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. It is also used to treat swelling (edema) caused by certain conditions (such as heart failure, liver disease) by removing excess fluid and improving symptoms such as breathing problems. This medication is also used to treat conditions in which the body is making too much of a natural substance (aldosterone). Spironolactone is known as a "water pill" (potassium-sparing diuretic). A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827) In 2024, this provider wrote 15 Medicare prescriptions for Spironolactone, about a third of the volume of the typical Massachusetts prescriber of this medication (40.1). Medicare paid an average of $16.21 per fill, versus $9.98 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 28 30-Day Fills standardized to 30-day supplies 840 Days of Medication total across all patients in 2024 | |||
| MounjaroTirzepatide | 15 | $1,053.62▼ below MA avg | ▼ Less than typical |
About Mounjaro: Tirzepatide is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. It lowers blood sugar by causing the release of your body's natural insulin and decreasing the amount of sugar your liver makes. An analog of GASTRIC INHIBITORY POLYPEPTIDE and agonist of GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR and GLUCAGON-LIKE PEPTIDE-1 RECEPTOR used to enhance glycemic control of TYPE 2 DIABETES MELLITUS. In 2024, this provider wrote 15 Medicare prescriptions for Mounjaro, about a third of the volume of the typical Massachusetts prescriber of this medication (46.1). Medicare paid an average of $1,053.62 per fill, versus $1,225.06 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 15 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| SynthroidLevothyroxine Sodium | 14 | $102.46 | ▼ Less than typical |
About Synthroid: Levothyroxine is used to treat an underactive thyroid (hypothyroidism). Show more ▾ It replaces or provides more thyroid hormone, which is normally produced by the thyroid gland. Low thyroid hormone levels can occur naturally or when the thyroid gland is injured by radiation/medications or removed by surgery. Having enough thyroid hormone is important for maintaining normal mental and physical activity. In children, having enough thyroid hormone is important for normal mental and physical development. This medication is also used to treat other types of thyroid disorders (such as thyroid cancer). This medication should not be used to treat infertility unless it is caused by low thyroid hormone levels. The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism. In 2024, this provider wrote 14 Medicare prescriptions for Synthroid, about half the volume of the typical Massachusetts prescriber of this medication (29.9). Medicare paid an average of $102.46 per fill, versus $59.24 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 30.8 30-Day Fills standardized to 30-day supplies 924 Days of Medication total across all patients in 2024 | |||
| Metformin Hcl ErMetformin Hcl | 14 | $11.94▼ below MA avg | ▼ Less than typical |
About Metformin Hcl Er: Metformin is used with a proper diet and exercise program and possibly with other medications to control high blood sugar. Show more ▾ It is used in patients with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Metformin works by helping to restore your body's proper response to the insulin you naturally produce. It also decreases the amount of sugar that your liver makes and that your stomach/intestines absorb. A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289) In 2024, this provider wrote 14 Medicare prescriptions for Metformin Hcl Er, about a quarter of the volume of the typical Massachusetts prescriber of this medication (51.5). Medicare paid an average of $11.94 per fill, versus $12.48 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 41.3 30-Day Fills standardized to 30-day supplies 1,239 Days of Medication total across all patients in 2024 | |||
| Insulin Lispro | 14 | $77.85 | ▼ Less than typical |
About Insulin Lispro: Insulin lispro is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin lispro is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. Insulin lispro starts working faster and lasts for a shorter time than regular insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. This medication is usually used with a medium- or long-acting insulin product. Insulin lispro may also be used with other oral diabetes medications (such as sulfonylureas like glyburide or glipizide). Insulin that has been modified so that the B-chain contains a LYSINE at position 28 instead of a PROLINE and a PROLINE at position 29 instead of a LYSINE. It is used to manage BLOOD GLUCOSE levels in patients with TYPE 2 DIABETES. In 2024, this provider wrote 14 Medicare prescriptions for Insulin Lispro, about 63% of the volume of the typical Massachusetts prescriber of this medication (22.1). Medicare paid an average of $77.85 per fill, versus $45.84 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill Gross Part D cost per fill; not the patient's out-of-pocket price. 24 30-Day Fills standardized to 30-day supplies 685 Days of Medication total across all patients in 2024 | |||
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $710.31▼ below MA avg | ▼ Less than typical |
About Toujeo Solostar: Insulin glargine is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin glargine is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin glargine may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 13 Medicare prescriptions for Toujeo Solostar, about half the volume of the typical Massachusetts prescriber of this medication (23.2). Medicare paid an average of $710.31 per fill, versus $737.27 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 18.2 30-Day Fills standardized to 30-day supplies 508 Days of Medication total across all patients in 2024 | |||
| Tresiba Flextouch U-200Insulin Degludec | 13 | $602.17▼ below MA avg | ▼ Less than typical |
About Tresiba Flextouch U-200: Insulin degludec is used with a proper diet and exercise program to control high blood sugar in people with diabetes. Show more ▾ Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems. Proper control of diabetes may also lessen your risk of a heart attack or stroke. Insulin degludec is a man-made product that is similar to human insulin. It replaces the insulin that your body would normally make. It acts longer than regular insulin, providing a low, steady level of insulin. It works by helping blood sugar (glucose) get into cells so your body can use it for energy. Insulin degludec may be used with a shorter-acting insulin product. It may also be used alone or with other diabetes drugs. In 2024, this provider wrote 13 Medicare prescriptions for Tresiba Flextouch U-200, about half the volume of the typical Massachusetts prescriber of this medication (30.2). Medicare paid an average of $602.17 per fill, versus $1,129.37 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 13 30-Day Fills standardized to 30-day supplies 341 Days of Medication total across all patients in 2024 | |||
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 12 | $779.73▼ below MA avg | ▼ Less than typical |
In 2024, this provider wrote 12 Medicare prescriptions for Omnipod 5 Dexg7g6 Pods (Gen 5), about a third of the volume of the typical Massachusetts prescriber of this medication (28.9). Medicare paid an average of $779.73 per fill, versus $1,165.82 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 14 30-Day Fills standardized to 30-day supplies 420 Days of Medication total across all patients in 2024 | |||
| Ulticare Pen NeedlePen Needle, Diabetic | 11 | $62.93▼ below MA avg | ▼ Less than typical |
In 2024, this provider wrote 11 Medicare prescriptions for Ulticare Pen Needle, about half the volume of the typical Massachusetts prescriber of this medication (18.5). Medicare paid an average of $62.93 per fill, versus $62.97 statewide. How often this provider prescribes it This provider prescribes this medication less often than the average MA prescriber. Utilization reflects practice size as well as clinical preference. What Medicare paid per fill This provider's average cost per fill is below the MA average for this medication. 11 30-Day Fills standardized to 30-day supplies 275 Days of Medication total across all patients in 2024 | |||
About this data. The prescription history for DR. MICHELE A GORTAKOWSKI M.D. is compiled from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Prescriber Public Use File for calendar year 2024, the most recent federal release. Figures cover prescriptions filled for Medicare Part D beneficiaries only; prescriptions under private insurance, Medicaid, or self-pay plans are not included. Because prescribing decisions are generally consistent across coverage types, this record offers a useful view of the overall Endocrinology, Diabetes & Metabolism prescribing approach at this Springfield, MA practice.
Reading the costs. Drug costs are gross amounts paid to pharmacies under Part D, including both plan and beneficiary payments. They are not the price a patient pays at the pharmacy counter. Medications with fewer than 11 claims are excluded from the federal source data, and state comparisons use the average among MA prescribers of the same medication and form, shown only when at least five prescribers contribute. Always confirm current medications and costs directly with the provider and your plan.
About the medication summaries. Drug use descriptions come from the CMS Medicare Part D Drug Spending Dashboard (2024), and substance definitions from Medical Subject Headings (MeSH) 2026, U.S. National Library of Medicine. They are summaries that do not contain all possible information about a medication and are not individual medical advice. Ask a health care professional about any medication and your specific health needs.
